Thomas Scientific inks distribution deal with Agilent

By The Science Advisory Board staff writers

July 20, 2021 -- Scientific products distributor Thomas Scientific has signed a strategic distribution deal with Agilent Technologies that will allow Thomas to offer a wide range of Agilent products for the molecular biology and diagnostics markets.

Under the agreement, Thomas Scientific will be able to offer its customers access to more than 700 Agilent bioreagent products, including quantitative polymerase chain reaction (qPCR) instruments, reagents, PCR enzymes, and other molecular biology reagents, according to the company.

In addition, Agilent's CRISPR libraries will also be available through Thomas Scientific.

Agilent debuts its full range of InfinityLab Bio LC products
Agilent Technologies has debuted three InfinityLab Bio liquid chromatography (LC) systems: the 1290 Infinity II Bio LC System with high-speed pump, the...
Agilent launches new exome design for genomics research
Agilent Technologies has released a new exome design that provides content for genomics research.
Agilent reports revenue increase for Q2
Agilent Technologies saw revenue exceed expectations for the company's second quarter, while net income more than doubled.
Agilent debuts immune cell analysis platform
Agilent Technologies has debuted its Seahorse extracellular flux (XF) HS miniplate that provides improved immune cell metabolic analysis.
Agilent offers new flow cytometers
Agilent Technologies has launched a new product offering, the Agilent NovoCyte Penteon, a flow cytometer with five lasers and up to 30 fluorescence channels.

Copyright © 2021 scienceboard.net


Conferences
BioTech Pharma Summit
September 27-28
Porto Portugal
Infectious Diseases (ID) Week 2021
September 29 - October 3
San Diego, California United States
Imaging Mass Spectrometry Society (IMSS) 3 in 2021
October 3-6
Colorado Springs, Colorado United States
Cell & Gene Meeting on the Mesa
October 10-14
Carlsbad, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter